Sandu Pharmaceuticals Q1 Results
- BSE: 524703
- NSE: -
- ISIN: INE751D01014
- Sector: Biotechnology & Drugs
BSE
53
2.24 (4.41%)
2.24 (4.41%)Volume1.00
Updated: Wed 19 Mar, 2025 | 09:07:14
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Sandu Pharmaceuticals Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Mar 24 | QoQ Comp | Jun 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 17.05 | 15.60 | 9.28% | 17.66 | -3.46% |
| Selling/ General/ Admin Expenses Total | 2.33 | 2.47 | -5.74% | 2.52 | -7.68% |
| Depreciation/ Amortization | 0.16 | 0.19 | -14.85% | 0.12 | 29.74% |
| Other Operating Expenses Total | 5.01 | 6.32 | -20.75% | 5.33 | -6.04% |
| Total Operating Expense | 16.80 | 15.18 | 10.66% | 17.42 | -3.59% |
| Operating Income | 0.25 | 0.42 | -40.87% | 0.23 | 5.74% |
| Net Income Before Taxes | 0.27 | 0.72 | -62.37% | 0.21 | 28.17% |
| Net Income | 0.16 | 0.59 | -72.31% | 0.11 | 49.91% |
| Diluted Normalized EPS | 0.47 | 0.61 | -23.48% | 0.11 | 323.98% |